首页> 中文期刊> 《临床与转化肝病杂志(英文版)》 >Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis

Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis

         

著录项

  • 来源
    《临床与转化肝病杂志(英文版)》 |2020年第3期|277-284|共8页
  • 作者单位

    Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China;

    Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China;

    Department of Liver Cirrhosis Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China;

    Department of Infectious Diseases Nanfang Hospital Southern Medical University Guangzhou Guangdong China;

    Department of Liver Cirrhosis Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China;

    Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China;

    Department of Infectious Diseases Ruijin North Hospital Shanghai Jiao Tong University School of Medicine Shanghai China;

    Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China;

    Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China;

    Discipline of Pathology School of Medicine Sciences and Bosch Institute Charles Perkin Centre University of Sydney New South Wales Australia;

    Department of Liver Cirrhosis Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号